Rastroyeniye "Trikafta"

Company MIK allowed start of productions a preparation from mukovistsidoza Structure of the Swiss Genfa Global of the former top manager "Biotek" Zhukovskoy Sergei considers production in Russian Federation analog of a preparation from mukovistsidoza "Trikaft". The market of it and drugs similar to it exceeds ₽2 billion a year the Medical research company (MIK) can localize in Russian Federation production the preparation "Trileksa" of the Argentina Tuteur. It is a question of analog (generic) of original Trikafta medicine of the American Vertex Pharmaceuticals Incorporated applied to treatment of patients with rare...